Do what you’re good at with 5-fold greater efficiency—and leave the rest to us.
We are pleased to announce that BellBrook Labs is partnering with the Lankenau Institute for Medical Research (LIMR) to provide access to an innovative Orthogonal Pooled Screening (OPS™) Platform. The OPS™ Platform provides drug discovery researchers with a drastically more efficient and less expensive approach for finding new leads from a pre-filtered library of more than 100,000 compounds. Compounds are custom dispensed into “assay-ready” 384 well plates at 10 compounds per well, with each compound in duplicate, for a net 5-fold decrease in the number of wells required for screening.
For example, you can screen a pilot set of 8,000 compounds in five 384-well plates, which can easily be accomplished using manual dispensing and plate-reading equipment. LIMR will identify hits based on your cut-off criteria using their proprietary data mining software and provide cherry-picked compounds for dose response and secondary assays.
Want to learn more?